Difference between revisions of "Factor VIII, recombinant"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "==General information== Class/mechanism: Recombinant Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.<br>P...")
 
m
(5 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
==General information==
 
==General information==
 
Class/mechanism: Recombinant Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.<br>Please choose from the products below to find specific drug/manufacturer information:
 
Class/mechanism: Recombinant Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.<br>Please choose from the products below to find specific drug/manufacturer information:
*Advate <ref>[http://advate.com/ Advate manufacturer's website]</ref><ref name="Advate">[http://advate.com/pdf/advate_iri_pi.pdf Factor VIII, recombinant (Advate) package insert]</ref><ref>[[Media:Factorviiiadvate.pdf | Factor VIII, recombinant (Advate) package insert (locally hosted backup)]]</ref>
+
*Advate <ref>[http://advate.com/ Advate manufacturer's website]</ref><ref name="Advate">[http://advate.com/pdf/advate_iri_pi.pdf Factor VIII, recombinant (Advate) package insert]</ref><ref>[[:File:Factorviiiadvate.pdf | Factor VIII, recombinant (Advate) package insert (locally hosted backup)]]</ref>
*Helixate FS <ref>[http://www.helixatefs.com/ Helixate FS manufacturer's website]</ref><ref name="Helixate">[http://labeling.cslbehring.com/PI/US/HelixateFS/EN/HelixateFS-Prescribing-Information.pdf Factor VIII, recombinant (Helixate FS) package insert]</ref><ref>[[Media:Factorviiihelixate.pdf | Factor VIII, recombinant (Helixate FS) package insert (locally hosted backup)]]</ref>
+
*Helixate FS <ref>[http://www.helixatefs.com/ Helixate FS manufacturer's website]</ref><ref name="Helixate">[http://labeling.cslbehring.com/PI/US/HelixateFS/EN/HelixateFS-Prescribing-Information.pdf Factor VIII, recombinant (Helixate FS) package insert]</ref><ref>[[:File:Factorviiihelixate.pdf | Factor VIII, recombinant (Helixate FS) package insert (locally hosted backup)]]</ref>
*Kogenate FS <ref>[https://www.kogenatefs.com Kogenate FS manufacturer's website]</ref><ref name="Kogenate">[http://labeling.bayerhealthcare.com/html/products/pi/Kogenate_BIO-SET_PI.pdf Factor VIII, recombinant (Kogenate FS) package insert]</ref><ref>[[Media:Factorviiikogenate.pdf | Factor VIII, recombinant (Kogenate FS) package insert (locally hosted backup)]]</ref>
+
*Kogenate FS <ref>[https://www.kogenatefs.com Kogenate FS manufacturer's website]</ref><ref name="Kogenate">[http://labeling.bayerhealthcare.com/html/products/pi/Kogenate_BIO-SET_PI.pdf Factor VIII, recombinant (Kogenate FS) package insert]</ref><ref>[[:File:Factorviiikogenate.pdf | Factor VIII, recombinant (Kogenate FS) package insert (locally hosted backup)]]</ref>
*Recombinate <ref>[http://www.recombinate.com/ Recombinate manufacturer's website]</ref><ref name="Recombinate">[http://www.recombinate.com/pdf/recombinate-pi-baxject-ii.pdf Factor VIII, recombinant (Recombinate) package insert]</ref><ref>[[Media:Factorviiirecombinate.pdf | Factor VIII, recombinant (Recombinate) package insert (locally hosted backup)]]</ref>
+
*Recombinate <ref>[http://www.recombinate.com/ Recombinate manufacturer's website]</ref><ref name="Recombinate">[http://www.recombinate.com/pdf/recombinate-pi-baxject-ii.pdf Factor VIII, recombinant (Recombinate) package insert]</ref><ref>[[:File:Factorviiirecombinate.pdf | Factor VIII, recombinant (Recombinate) package insert (locally hosted backup)]]</ref>
*ReFacto <ref name="Refacto">[http://www.abopharmaceuticals.com/ProductSheets/Refacto.pdf Factor VIII, recombinant (ReFacto) package insert]</ref><ref>[[Media:Factorviiirefacto.pdf | Factor VIII, recombinant (ReFacto) package insert (locally hosted backup)]]</ref>
+
*ReFacto <ref name="Refacto">[http://www.abopharmaceuticals.com/ProductSheets/Refacto.pdf Factor VIII, recombinant (ReFacto) package insert]</ref><ref>[[:File:Factorviiirefacto.pdf | Factor VIII, recombinant (ReFacto) package insert (locally hosted backup)]]</ref>
*Xyntha <ref>[http://www.xyntha.com/ Xyntha manufacturer's website]</ref><ref name="Xyntha">[http://labeling.pfizer.com/showlabeling.aspx?id=496 Factor VIII, recombinant (Xyntha) package insert]</ref><ref>[[Media:Factorviiixyntha.pdf | Factor VIII, recombinant (Xyntha) package insert (locally hosted backup)]]</ref>
+
*Xyntha <ref>[http://www.xyntha.com/ Xyntha manufacturer's website]</ref><ref name="Xyntha">[http://labeling.pfizer.com/showlabeling.aspx?id=496 Factor VIII, recombinant (Xyntha) package insert]</ref><ref>[[:File:Factorviiixyntha.pdf | Factor VIII, recombinant (Xyntha) package insert (locally hosted backup)]]</ref>
 
Route: IV
 
Route: IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.
  
 
==Diseases for which it is used==
 
==Diseases for which it is used==
Line 31: Line 31:
 
<references/>
 
<references/>
  
[[Category:Drug index]]
+
[[Category:Drugs]]
 
[[Category:Intravenous medications]]
 
[[Category:Intravenous medications]]
 +
[[Category:Inherited coagulopathy medications]]
 +
[[Category:Recombinant medications]]
 +
 
[[Category:Hematology medications]]
 
[[Category:Hematology medications]]
 
[[Category:Hemostasis medications]]
 
[[Category:Hemostasis medications]]
 
[[Category:Coagulation factors]]
 
[[Category:Coagulation factors]]

Revision as of 14:35, 28 February 2024

General information

Class/mechanism: Recombinant Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.
Please choose from the products below to find specific drug/manufacturer information:

Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.

Diseases for which it is used

  • Hemophilia A

Patient drug information

Also known as

  • Generic name: recombinant coagulation factor 8
  • Brand names: Advate rAHF-PFM, Helixate, Helixate FS, Kogenate, Kogenate FS, Recombinate, Refacto, Xyntha

References